Gabriele Kuttner

Title: Gabriele Kuttner: Innovator in Metal-Binding Peptides

Introduction

Gabriele Kuttner is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of diagnostics and therapeutics through his innovative work on metal-binding peptides. His research focuses on developing cysteine-free peptides that can be utilized for organ-specific imaging and treatment.

Latest Patents

Kuttner holds a patent for "Metal-binding cystein-free peptides for diagnostic and therapeutical purposes, methods for their production, and pharmaceuticals containing these compounds." This invention relates to metal-complexing, cysteine-free peptides that can be coupled to organ-specific probes. These peptides are designed to be enriched as conjugates specifically in tumors, organs, tissues, or centers of inflammation. The organ-specific probes used include antibodies or part-sequences of antibodies against tumor-associated antigens, such as the carcino-embryonal antigen (CEA). The invention also encompasses processes for producing these metal-complexing peptides and their conjugates, which can be used in kits for in vivo diagnosis or therapy, as well as in radio-pharmaceuticals.

Career Highlights

Gabriele Kuttner is associated with Institut für Diagnostikforschung GmbH, where he continues to advance his research in the field of peptide technology. His work has the potential to significantly impact the way tumors and inflammatory conditions are diagnosed and treated.

Collaborations

Kuttner collaborates with esteemed colleagues such as Sebastian Erber and Reinhard Malin, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Gabriele Kuttner's contributions to the field of metal-binding peptides highlight his role as a pioneering inventor. His work not only advances scientific knowledge but also holds promise for improving diagnostic and therapeutic strategies in medicine.